The clinical outcomes of patients who developed typical atrial flutter on class 1C anti arrhythmic medications treated with hybrid approach

INTRODUCTION: A common approach to patients, who developed atrial flutter secondary to treatment with class 1C anti‐arrhythmic drugs for atrial fibrillation (AF) (1C flutter), is a hybrid approach: ablation of the Cavo‐Tricuspid isthmus (CTI) and continuation 1C medical treatment to prevent recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossman, Lior, Katz, Moshe, Beinart, Roy, Nof, Eyal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605003/
https://www.ncbi.nlm.nih.gov/pubmed/31056764
http://dx.doi.org/10.1002/clc.23193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605003/
https://www.ncbi.nlm.nih.gov/pubmed/31056764
http://dx.doi.org/10.1002/clc.23193

Ejemplares similares